-+ 0.00%
-+ 0.00%
-+ 0.00%

Allarity Therapeutics Sees Q4 GAAP EPS $0.01-$0.04

Benzinga·11/13/2026 13:29:23
Listen to the news

Allarity Therapeutics (NASDAQ:ALLR) is looking for Q4 GAAP EPS of $0.01-$0.04